News

CardioDx Inc. is a molecular diagnostics company specializing in cardiovascular genomics. It...

Combining genetic data with clinical information to determine the initial dosage of the blood thinner warfarin, used to prevent blood clots in the circulatory system, was no more effective in...

PDI, Inc. and Transgenomic, Inc. announced the signing of a U.S. collaboration agreement to commercialize CardioPredict, a molecular diagnostic test developed by Transgenomic. CardioPredict is a...

University of Maryland Medical Center Genetic-Testing Program Cardiac Stent

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on information found in their genes. As part...

March 7, 2013 — A newly identified genetic variant doubles the risk of calcium buildup in the heart’s aortic valve. Calcium buildup is the most common cause of aortic stenosis, a narrowing of the...

Laboratory Corporation of America Holdings (LabCorp) announced it has launched its clinical next generation sequencing assay, GeneSeq: Cardio for genetic causes of familial cardiac disease.

August 9, 2012 — CardioDx Inc. announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the company’s Corus CAD gene...

January 4, 2012 - A study reported in the current issue of Pediatric and Developmental Pathology compares cardiac tissue from 12 patients with histiocytoid cardiomyopathy (HC)...

November 15, 2011 — A clinical trial of patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) and stable angina showed rapid genotyping followed by...

August 17, 2011 — A scientist at the Gladstone Institutes has discovered how a gene known as SIRT3 contributes to a suite of health problems, offering new insight into how to combat these...

March 1, 2011 – A new study assessing the utility of genetic testing to determine a personalized warfarin dose for individual patients has begun at Overlake Hospital Medical Center in Bellevue,...

February 25, 2011 – A diagnostic test used to help treat patients with high cholesterol received CE mark approval in Europe. The KIF6 genotyping assay, from Abbott, detects a genetic marker that...

February 4, 2011 – Researchers at the National Institutes of Health's (NIH) Undiagnosed Diseases Program (UDP) have identified the genetic cause of a rare and debilitating vascular disorder not...

January 31, 2011 – Parental history of heart disease nearly doubles a person’s risk in all regions of the world, even after considering all other known risk factors of heart disease. The results...

October 28, 2010 - The first patent related to specific human blood protein variant biomarkers related to cardiovascular disease has been issued. The United States Patents and Trademark Office has...

May 14, 2010 — A partnership to develop cardiovascular genomic diagnostic testing devices has been signed between GE Healthcare and CardioDx.

March 24, 2010 — Several genes are associated with heart disease, stroke, and high blood pressure, and can determine whether people may have predisposition to these conditions, according to...

November 17, 2009 – A new genetic test to detect familial dilated cardiomyopathy (DCM), the FAMILION DCM Test, was introduced this week at the 2009 American Heart Association (AHA) meeting in...

October 16, 2009 – Correlagen recently expanded its CardioGeneScan test, the first comprehensive genetic test for the diagnosis of familial cardiac disease.

September 1, 2009 – CardioDx said last week it successfully completed its multicenter validation study for Corus CAD, the first gene expression test to quantify the likelihood of obstructive(1)...

July 9, 2009 – According to Millennium Research Group (MRG), the ongoing economic crisis is putting pressure on publicly funded European healthcare systems, intensifying the decline of...

June 5, 2009 - Utilizing next generation sequencing and the latest advancements in sequence capture, genomic and molecular biology services company SeqWright, is collaborating with Roche Applied...

April 20, 2009 - BioReference Laboratories Inc. is now offering next- generation sequencing testing for Dilated Cardiomyopathy (DCM) through its GeneDx laboratory.

April 9, 2009 - According to research presented last week at ACC, patients with the CYP2C19*2 genotype had more ischemic events in the one year following percutaneous coronary intervention (PCI...

March 20, 2009 - ARCA biopharma Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, said today two Gencaro (bucindolol...

March 20, 2009 - BRAHMS AG of Hennigsdorf, Germany and Annapolis, MD, recently submitted a 510(k) file to the FDA to market its patented BRAHMS MR-proANP Kryptor Test used to find biomarkers for...

February 19, 2009 - Molecular diagnostic company TrimGen Corp. has received FDA 510(k) clearance to market its eQ-PCR LC Warfarin Genotyping kit, an assay used to aid identification of patients...

August 28, 2008 - Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE),...

August 1, 2008 - Osmetech said this week at the American Association for Clinical Chemistry (AACC) 2008 Conference and Exhibition in Washington, D.C., that following receipt of its 510(k)...

July 22, 2008 - Osmetech today said it received FDA 510(k) clearance for its eSensor Warfarin Sensitivity Test to be used as an aid in the identification of patients at risk for increased...

July 22, 2008 - CyGene Laboratories Inc. this week is introducing StrokeScan, a genetic screening test aimed at identifying high risk individuals who have a family history of stroke,...

December 27, 2007 - Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages are among the top...

October 16, 2007 – Celera developed a five-gene genetic risk score based on five variant genes that predict risk for coronary heart disease (CHD), according to a study published in the October...

October 1, 2007 – GE Global Research, the General Electric Company’s centralized research and development organization, and GE Healthcare today announced a three-year collaborative research...

June 18, 2007 – BioServe today announced that it has been selected by Houston-based Specialized Clinical Center of Research (SCCOR) for a novel study aimed at identifying the genetic cause of...

Feb 9, 2007 — Research spanning three decades links a newly discovered gene variant in women to greater susceptibility to developing heart disease.